Researchers at the Paul Scherrer Institute PSI and the
University of Basel have developed a rapid test for COVID-19. Its
novel functional principle promises reliable and quantifiable
results concerning a patient’s COVID-19 disease and its course—as
well as evidence concerning other diseases and COVID variants that
may be present. Before it can go into widespread use, however, it
still must undergo further testing and optimisation. The
researchers report on their development in the journal ACS Applied
Nanomaterials.
